🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Avata, Oceanus partner on #cannabidiol for #epilepsy, #schizophrenia bioworld.com/articles/721340 #biopharma #deal #CBD

Jyong’s $20M US #IPO to help refile NDA of urological botanic drug bioworld.com/articles/721456 #biopharma #financing #botanical #urology

Cheering Immuneering Corp, Street hopes high in #pancreaticcancer bioworld.com/articles/721338 #biopharma #clinical

An early stage 85% remissions rate in #AML drives Aptevo Therapeutics’s stock surge bioworld.com/articles/721337 #biopharma #cancer #clinical #oncology @aabvie

US universities developing alternative to cover indirect costs bioworld.com/articles/721339 #biopharma NIH

#BIO2025: Makary lays out #FDA’s path, launches pilot review program (free w/ one-time registration) bioworld.com/articles/721335 #biopharma Biotechnology Innovation Organization

Newly launched #Draig targeting #depression with $140M series A bioworld.com/articles/721336 #biopharma #financing

An early stage 85% remissions rate in #AML drives Aptevo Therapeutics’s stock surge bioworld.com/articles/721337 #biopharma #cancer #clinical #oncology @aabvie

Cheering Immuneering Corp, Street hopes high in #pancreaticcancer bioworld.com/articles/721338 #biopharma #clinical

US universities developing alternative to cover indirect costs bioworld.com/articles/721339 #biopharma NIH

Avata, Oceanus partner on #cannabidiol for #epilepsy, #schizophrenia bioworld.com/articles/721340 #biopharma #deal #CBD

Jyong’s $20M US #IPO to help refile NDA of urological botanic drug bioworld.com/articles/721456 #biopharma #financing #botanical #urology

NICE rejects Eli Lilly and Company‘s Kisunla and @Eisai‘s Leqembi (free w/ one-time registration) bioworld.com/articles/721431 #biopharma

CBER shakeup points to further U.S. FDA realignment bioworld.com/articles/721432 #biopharma #raredisease #DMD #cellandgenetherapy #regulatory

CHMP recommends approval of Rezdiffra, Ogsiveo and others bioworld.com/articles/721433 #biopharma EU Medicines Agency

.U.S. FDA scrutinizing trials sending US patient cells to China bioworld.com/articles/721434 #biopharma

#HAE research continues to swell post-CSL Andembry win bioworld.com/articles/721435 #biopharma

Drug Farm harvests new #immunomodulators with #AI #geneediting tech bioworld.com/articles/721436 #biopharma #deal #hepatitisB

Keymed launching Stapokibart, advancing pipeline, with $125M raise bioworld.com/articles/721506 #biopharma #financing

Immuno Cure, Temp partner on needle-free #HIV #vaccine trial bioworld.com/articles/721505 #infectiousdisease #AIDS